新聞集錦
NEW

11/18《生技股動態》
政策法規
NEW

韓國對數位療法提供從監管到給付的積極政策

新聞集錦
NEW

新加坡攜非洲CDC強化M痘檢測能量；禮來新加坡設數位健康創新中心

GBI International
GBIHighlights

Reflecting on 2023: a year filled with hope, challenges, and resilience in biomedicine

2023-12-31/GlobalBio & Investment
Reflectingon2023:ayearfilledwithhope,challenges,andresiliencein #biomedicine.Let’srevisitthehighlightsandembrace2024withenthusiasm! Wewanttothankyouforyourunwaveringsupportinexploringthewonderso...
GBI International
GBIHighlights

Join BE Health's Proof of Clinical Evidence Acceleration Program before the deadline!

2023-12-31/GlobalBio & Investment
Callallinnovators!JoinBEHealth's #PoC (ProofofClinicalEvidence)AccelerationProgrambeforethedeadline!Tailoredforprecisionmedicine,medicaldevices,anddigitalhealth,itoffers5-6monthsofsupport,a$500,00...
GBI International
GBI Highlights

AdvMeds now serves 12 countries with 3 million+ users worldwide!

2023-12-31/GlobalBio & Investment
Breakingtheboundaries!AdvMeds,ahealthcareinformationsystemcompanyfromTaiwan,nowserves12countrieswith3million+usersworldwide!DuringCOVID-19,AdvMedsstoodoutbyprovidingdigitalhealthcaresolutionsandpartne...
GBI International
GBIHighlights

Prof. Cheng-Hsun Chiu emphasizes the critical need for a "Virology to Clinical Blueprint"

2023-12-31/GlobalBio & Investment
Preparetoprevent#2:WeareexcitedtoshareinsightsfromProf.Cheng-HsunChiu,DeputySuperintendentat 長庚醫院.HeisalsotheleaderofAdvageneBiopharma'sCOVID-19drugAD17002-SC'sphase2atrial.Prof.Chiuemphasizes...
GBI International
GBI Highlights

Meet the startup CEO, Bon Lee, CEO of MedFluid Co., Ltd.

2023-12-31/GlobalBio & Investment
MeetthestartupCEO.BonLee,CEOof MedFluidCo.,Ltd. shiftedfromengineertoentrepreneur,valuingproblem-solving.Butleadingacompanydemandsmore!Prioritizingrevenuemeansfocusingonurgentuserneedsandcreatingswift...
GBI International
GBIHighlights

Dr. Tse Wen Chang, Taiwan's antibody pioneer, invented Xolair which was the first anti-IgE antibody

2023-12-31/GlobalBio & Investment
Excitingnewsintheantibodyworld!Dr.TseWenChang,Taiwan'santibodypioneer,inventedXolair(#omalizumab)whichwasthefirstanti-IgEantibody.FDAisexpectedtoreviewitssBLAsubmittedbyRocheforfoodallergybyQ12024...
GBI International
GBIHighlights

Learn from Dr. Andrea Carfi, Moderna’s Chief Scientific Officer, about their mRNA library...

2023-12-31/GlobalBio & Investment
Preparetoprevent#1Prepareforthenextpandemic?Moderna’svaccinestrategyisunderway!Howdotheyusepastexperiencestoswiftlydevelopvaccinesagainstunknownthreats?LearnfromDr. AndreaCarfi, Moderna’sC...
GBI International
GBIHighlights

Jellox partnered with China Medical University Hospital to bring digital pathology tech to Malaysia

2023-12-31/GlobalBio & Investment
Kudosto JelloXBiotechInc. foradvancinghealthcaredigitizationinMalaysia!!JelloxpartneredwithChinaMedicalUniversityHospital(#CMUH)tobringdigitalpathologytechtoMalaysiaunderTaiwan's"OneCountry,O...
GBI International
GBIHighlights

BRIM Biotechnology, Inc. ’s dry eye drug missed the primary goal in its late-stage trial

2023-12-31/GlobalBio & Investment
Everysetbackisasteppingstone!Thejourneyofdrugdevelopmentisascientificexploration.Eachhurdleisn’ttheendgame. BRIMBiotechnology,Inc. ’sdryeyedrugmissedtheprimarygoalinitslate-stagetrial.What...
GBI International
GBIHighlights

19 precision testing groups formed the International Precision Testing Industry Alliance

2023-12-31/GlobalBio & Investment
Unityisstrength!19precisiontestinggroupsformedthe"InternationalPrecisionTestingIndustryAlliance"(#LDTS Alliance)inDecember2023.RogerLiu,LDTSAlliance'sChairmanandCEOat 亞洲準譯AsiaPathogenomi...
GBI International
GBIHighlights

TAVI compiled over a century of Taiwan's vaccine history into the book

2023-12-31/GlobalBio & Investment
Knowledgeispower.TheTaiwanAssociationforVaccineIndustry(#TAVI)recentlycompiledoveracenturyofTaiwan'svaccinehistoryintothebook"AChronicleofTaiwan'sVaccineIndustry.",whichaimstopassonk...
GBI International
GBIHighlights

Win favor with Japanese investor: Insights from the 2023 Medtech Starthub

2023-12-31/GlobalBio & Investment
WanttowinfavorwithJapaneseinvestors?Focusonworkplacecultureandstrongpartnerships.Diveintotheinsightsfromthe2023MedtechStarthubeventwith #Globalbio'srecap! ReadmoretodiscoverthekeystocapturingJapan...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務